Drugs / Lactolevure
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| — | NCT04178187 Comparator | Oct 2019 → Dec 2021 | Helicobacter pylori infectious disease | Evangelismos Hospital | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Lactolevure | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04178187 ↗ |
| Modality | Other / unclassified | “The probiotic (Lactolevure, Uni-Pharma, Athens) contains four probiotic strains” NCT04178187 ↗ |